AeroRx Therapeutics Presents Positive Phase 2a Data for Inhaled AERO-007, the First Potential Nebulized LABA+LAMA Fixed-Dose Combination in Development for COPD

by | May 19, 2026 | Press Release

About Team Pipeline News Investors Contact About    Team    Pipeline    News    Investors   Contact About    Team    Pipeline News    Investors   Contact Press Release AeroRx Therapeutics Presents Positive Phase 2a Data for Inhaled AERO-007, the First Potential...

AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage Clinical Development

by | Oct 6, 2025 | Press Release

About Team Pipeline News Investors Contact About    Team    Pipeline    News    Investors   Contact About    Team    Pipeline News    Investors   Contact Press Release AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First...